Drug shortage: Heparin Sodium Injection (HEPARIN SODIUM IN SODIUM CHLORIDE, HEPARIN SODIUM)
FDA lists 8 presentations as Current. Availability: Unavailable (1), Limited Availability (3), Available (4). Reason: Demand increase for the drug; Other. Companies: Baxter Healthcare, Fresenius Kabi USA, LLC, Hospira, Inc., a Pfizer Company, B. Braun Medical Inc..
- Published by source
- 2017-11-14
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Baxter Healthcare
- Products
- Heparin Sodium Injection HEPARIN SODIUM IN SODIUM CHLORIDE HEPARIN SODIUM
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: December 2026
- Next release November 2026. Check wholesalers for inventory.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2017-11-14
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #891 | new | 2026-10-22 | ea1142e73415…eb7a4b | 2a5d59ddc0cd…342903 |
Chain head: #1094 edf3be25ec2e…478842